Citius Pharmaceuticals to be added to Russell 3000, Russell 2000 Indexes

Citius Pharmaceuticals announced that it is set to be added to the broad-market Russell 3000 Index and the small-cap Russell 2000 Index at the conclusion of the annual reconstitution of Russell US Indexes, effective at the opening of the U.S. equity markets on June 26, 2023. “We are pleased to be included, once again, in the Russell U.S. Equity Indexes and welcome the enhanced visibility this brings to our diversified late-stage pipeline,” stated Leonard Mazur, Chairman and CEO of Citius.